...
首页> 外文期刊>Psychiatry and Clinical Psychopharmacology >Personality Traits of Schizophrenic Patients in Remission and Their First-Degree Relatives: A Dopaminergic and Glutamatergic Gene Polymorphism Study
【24h】

Personality Traits of Schizophrenic Patients in Remission and Their First-Degree Relatives: A Dopaminergic and Glutamatergic Gene Polymorphism Study

机译:缓解期精神分裂症患者及其一级亲属的人格特征:多巴胺能和谷氨酸能基因多态性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The dopaminergic and glutamatergic systems are of major interest in the etiology of schizophrenia and supposed endophenotypes such as personality traits. In the present study, we investigated the association between the catechol-O-methyltransferase (COMT) gene P2 promoter rs2075507, Val/ Met (rs4680), the dopamine transporter gene (DAT1) VNTR and the glutamate transporter gene (SLC1A2) promoter -181A/C polymorphisms, and personality traits as well as symptomatic features in schizophrenia.Methods: There were 112 healthy subjects, 51 schizophrenic patients in remission for at least six months and 45 first-degree relatives of the patients enrolled in the study. The samples were genotyped for the COMT P2 promoter rs2075507, Val/Met, DAT1 VNTR and SLC1A2 promoter -181A/C polymorphisms and assessed with the Temperament and Character Inventory (TCI). Schizophrenia patients were also evaluated using the Operational Criteria Checklist for Psychotic Illness (OPCRIT) for each of the five factor-derived scales (negative symptoms, delusions, hallucinations, mania, and depression) and The Positive and Negative Symptom Scale.Results: Our findings demonstrate that schizophrenic patients, even after remission, had a different personality pattern from controls, showing higher scores in harm avoidance and self-transcendence and lower scores in novelty seeking, persistence, self-directedness and cooperativeness. First-degree relatives of patients also had profiles distinguishable from those of the patients only by intermediate levels of harm-avoidance and higher levels of cooperativeness. In the association of genotypes and personality, COMT Val/Met polymorphism was not associated with personality in patients or in healthy subjects. Another functional polymorphism in the COMT gene the P2 promoter rs2075507 G allele was associated with significantly higher novelty seeking scores in patients than was the A allele. DAT1 VNTR long alleles (10 or 11 repeats) were demonstrated to show a non-significant trend to association with higher self-transcendence scores than in those with the short alleles (3, 7, 8 or 9 repeats) in control samples and patients. In SLC1A2 promoter -181A/C polymorphism, the C allele was significantly associated with higher self-transcendence scores than in those with the A allele in healthy subjects. We did not find any associations between the psychotic symptom dimensions of patients and DAT1 VNTR, SLC1A2 promoter -181A/C and COMT Val/Met polymorphism; however, COMT P2 promoter rs2075507 polymorphism showed an association with the delusion and mania factor scores.Conclusions: Schizophrenia may be associated with different personality patterns from controls and some personality dimensions may be associated with the appearance of psychotic symptoms. The same genes may be responsible for the development of the disease, with personality patterns seen in at least one group of patients.?ZETAma?: Dopaminerjik ve glutamaterjik sistem, ?izofreninin ve ?izofreni ile ili?kili oldu?u ?ng?rülen ki?ilik ?zellikleri gibi endofe-notiplerin etyolojisinde ?nemli ilgi alanlar? aras?nda yer almaktad?r. Bu ?al??mada katekol-o-metil transferaz (COMT) geni P2 promoter rs2075507 ve Va l/Met (rs4680) polimorfizmleri, dopamin transporter geni (DAT1) VNTR ve glutamat transporter geni (SLC1A2) promoter 181 A/C polimorfizmlerinin ki?ilik ?zelliklerinin yan? s?ra ?izofreninin semptomatik ?zellikleri ile ili?kisinin ara?t?r?lmas? ama?lanm??t?r.Y?ntem: ?al??maya 112 sa?l?kl? kontrol, en az 6 ayd?r remisyonda olan 51 ?izofreni hastas? ve 45 birinci derece hasta yak?n? al?nm??t?r. Denekler COMT P2 promoter rs2075507, val/met, DAT1 VNTR ve SLC1A2 promoter -181A/C polimorfizmleri y?nünden genotiplendirilmi? ve Karakter ve Miza? Envanteri ile de?erlendirilmi?tir. ?izofreni hastalar? ayr?ca PANSS ve Psikotik Hastal?k i?in Operasyonel Kriterler Kontrol Listesi'nden (Operational Criteria Checklist for Psychotic Illness/OPCRIT) elde edilen be? fakt?r skalas? (negatif semptomlar, delüzyonlar, halusinasyonlar, mani ve depresyon) ile de?erlendirilmi?tirBulgular: ?al??mam?z ?izofreni hastalar?n?n remisyon sonras?nda bile sa?l?kl? kontrollerden farkl? bir ki?ilik paternine; zarardan ka??nmada ve kendini a?mada daha yüksek skorlara; yenilik aray???, sebatkarl?k, kendini y?netme ve i?birli?i yapmada daha dü?ük skorlara sahip olduklar?n? g?stermi?tir. ?izofreni hastalar?n?n birinci derece yak?nlar? ise hastalardan orta düzeyde zarardan ka??nma ve daha yüksek i?birli?i yapma skorlar? ile ayr??m??lard?r. Genotipler ve ki?ili?in ili?kisi incelendi?inde, COMT val/met polimorfizminin hastalarda veya sa?l?kl? kontrollerde ki?ilikle ili?kisi saptanmam??t?r. COMT geninde di?er bir foksiyonel polimorfizm olan P2 promoter rs2075507 G aleli, ?izofreni hastalar?nda istatistiksel anlaml? olarak A alelinden daha yüksek yenilik aray??? skorlar?yla ili?kiliydi. DAT1VNTR polimorfizmi uzun alelleri (10 ve 11 tekrar) hastalarda ve sa?l?kl? kontrollerde k?sa allerde
机译:目的:多巴胺能和谷氨酸能系统在精神分裂症的病因学和假定的内表型(如人格特质)方面具有重要意义。在本研究中,我们调查了儿茶酚-O-甲基转移酶(COMT)基因P2启动子rs2075507,Val / Met(rs4680),多巴胺转运蛋白基因(DAT1)VNTR和谷氨酸转运蛋白基因(SLC1A2)启动子-181A之间的关联方法:共有112名健康受试者,51名至少六个月缓解的精神分裂症患者和45名一级亲属参与了精神分裂症患者的/ C多态性,人格特征和症状特征。对样品进行COMT P2启动子rs2075507,Val / Met,DAT1 VNTR和SLC1A2启动子-181A / C多态性的基因分型,并用气质和性状量表(TCI)进行评估。还对精神分裂症患者的精神病疾病操作标准清单(OPCRIT)评估了五个因素衍生的量表(阴性症状,妄想,幻觉,躁狂症和抑郁症)和阳性和阴性症状量表。证明即使在缓解后,精神分裂症患者的人格特征也与对照组不同,在避免伤害和自我超越方面得分较高,在新颖性,坚持,自我导向和合作方面得分较低。患者的一级亲属也具有与患者不同的特征,仅在于避免伤害的中间水平和较高的合作水平。在基因型和人格的关联中,COMT Val / Met多态性与患者或健康受试者的人格无关。与A等位基因相比,COMT基因P2启动子rs2075507 G等位基因的另一个功能多态性与患者新奇寻求评分显着相关。在对照样品和患者中,DAT1 VNTR长等位基因(10或11个重复)显示出与自我超越得分更高的自我超越分数相关的非显着趋势,而短等位基因(3、7、8或9个重复)更高。在SLC1A2启动子-181A / C多态性中,健康受试者中C等位基因的自我超越得分显着高于A等位基因。我们没有发现患者的精神症状与DAT1 VNTR,SLC1A2启动子-181A / C和COMT Val / Met多态性之间有任何关联。结论:精神分裂症可能与对照组的不同人格特征有关,某些人格维度可能与精神病症状的出现有关。相同的基因可能是导致疾病发展的原因,至少在一组患者中出现了人格特征。ZETAma:多巴胺,谷氨酰胺,西非肾素,西非肾炎,老年痴呆和老年痴呆。 ki?ilik?zellikleri gibi endofe-notiplerin etyolojisinde?nemli ilgi alanlar?阿拉斯·恩达·耶尔·阿尔玛克塔德河Bu?al ?? mada katekol-o-metil transferaz(COMT)geni P2启动子rs2075507 ve Val / Met(rs4680)polimorfizmleri,多巴胺转运蛋白geni(DAT1)VNTR ve谷氨酸转运蛋白geni(SLC1A2)启动子181 A / C poliinfizml ?ilik?zelliklerinin yan? s?ra?izofreninin semptomatik?zellikleri ile ili?kisinin ara?t?r?lmas? ama?lanm ?? t?r.Y?ntem:?al ?? maya 112 sa?l?kl? kontrol,en az 6 ayd?r remisyonda olan 51?izofreni hastas? ve 45 birinci derece hasta yak?n? al?nm ?? t?r。 Denekler COMT P2启动子rs2075507,val / met,DAT1 VNTR ve SLC1A2启动子-181A / C polimorfizmleri y?nündengenotiplendirilmi? ve Karakter ve Miza? Envanteri ile de?erlendirilmi?tir。 ?izofreni hastalar? ayr?ca PANSS ve Psikotik Hastal?k i?in Operasyonel Kriterler Kontrol Listesi'nden(精神病/ OPCRIT的手术标准清单)还是艾德琳? fakt?r skalas? (negatif semptomlar,delüzyonlar,halusinasyonlar,mani ve depresyon)ile de?erlendirilmi?tirBulgular:?al ?? mam?z?izofreni hastalar?n?n remisyon sonras?nda bile sa?l?kl? kontrollerden farkl? bir ki?ilik paternine; zarardan ka ?? nmada ve kendini a?mada dahayüksekskorlara; yenilik aray ???,sebatkarl?k,kendini y?netme ve i?birli?i yapmada dahadü?k skorlara sahip olduklar?n? g?stermi?tir。 ?izofreni hastalar?n?n birinci derece yak?nlar? ise hastalardan ortadüzeydezarardan ka ?? nma ve dahayükseki?birli?i yapma skorlar? ile ayr ?? m ?? lard?r。 Genotipler ve ki?ili?in ili?kisi incelendi?inde,COMT val / met polimorfizminin hastalarda veya sa?l?kl? kontrollerde ki?ilikle ili?kisi saptanmam ?? t?r。 COMT geninde di?er bir foksiyonel polimorfizm olan P2启动子rs2075507 G Aleli,?izofreni hastalar?nda istatistiksel anlaml? olarak一个alelinden dahayüksekyenilik aray ??? skorlar?yla ili?kiliydi。 DAT1VNTR polimorfizmi uzun alelleri(10 ve 11 tekrar)hastalarda ve sa?l?kl? kontrollerde k?sa allerde

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号